XML 31 R76.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Based Compensation - Narrative (Details)
12 Months Ended 1 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 12 Months Ended
Dec. 31, 2012
USD ($)
Dec. 31, 2011
USD ($)
Dec. 31, 2010
USD ($)
Dec. 31, 2012
Stock Options
USD ($)
Dec. 31, 2011
Stock Options
USD ($)
Dec. 31, 2010
Stock Options
USD ($)
Dec. 31, 2012
Stock Appreciation Rights (SARs)
USD ($)
May 31, 2010
Third Amended and Restated 1997 Stock Option Plan
Stock Options
Dec. 31, 2012
Third Amended and Restated 1997 Stock Option Plan
Stock Options
USD ($)
Dec. 31, 2012
Third Amended and Restated 1997 Stock Option Plan
Stock Options
CAD
Dec. 31, 2011
Third Amended and Restated 1997 Stock Option Plan
Stock Options
USD ($)
Dec. 31, 2011
Third Amended and Restated 1997 Stock Option Plan
Stock Options
CAD
Dec. 31, 2010
Third Amended and Restated 1997 Stock Option Plan
Stock Options
USD ($)
Dec. 31, 2010
Third Amended and Restated 1997 Stock Option Plan
Stock Options
CAD
Dec. 31, 2012
Third Amended and Restated 1997 Stock Option Plan
Stock Options
Maximum
Dec. 31, 2012
Third Amended and Restated 1997 Stock Option Plan
Stock Options
Minimum
Mar. 31, 2012
Stock Bonus Plan
Performance Shares
USD ($)
Dec. 31, 2012
Stock Bonus Plan
Performance Shares
Dec. 31, 2011
Stock Bonus Plan
Performance Shares
Dec. 31, 2012
Deferred Share Units Plan
Deferred Share Units
USD ($)
Dec. 31, 2012
Deferred Compensation, Share-based Payments
USD ($)
Dec. 31, 2011
Deferred Compensation, Share-based Payments
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                            
Exercisable period for opions granted               10 years                            
Number of option shares authorized under the Plan                 25,000,000 25,000,000               900,000        
Number of option shares available for grant under the Plan                 5,029,646 5,029,646                        
Options vesting period - Range             3 years               3 years 0 years            
Options granted (options)       5,164,000 2,288,000 1,599,000     5,164,000 5,164,000 2,288,000 2,288,000 1,599,000 1,599,000                
Weighted average grant date fair value - nonvested option granted (Cdn$ per share)       $ 1.21 $ 1.78 $ 2.54     $ 1.20       $ 2.54                  
Options exercised - Aggregate intrinsic value                 $ 100,000 125,000 $ 300,000 0 $ 2,400,000 2,423,000                
Unrecognized compensation expense related to deferred share units                                       0    
Weighted average recognition period for unrecognized compensation expense 2 years                                          
Total fair value of shares vested during the years ended 3,700,000 3,600,000 2,900,000                                      
Common shares issued in period                                 165,009 710,854 0      
Value of shares issued in period                                 300,000          
Number of Golden Star common shares to be received for each DSU                                       $ 1    
Total stock compensation expense 6,111,000 3,385,000 2,975,000       300,000                           600,000 49,500
Equity instruments (other than options) granted in period             1,543,043                              
Equity instruments (other than options) forfeited in period             463,636                              
Number of equity instruments (other than options) outstanding             1,079,407                              
Total unrecognized compensation cost             $ 800,000                              
Options exercised - Weighted average exercise price                   1.45   1.78   2.11